Show Answer<\/span><\/a><\/div>
No<\/strong><\/div><\/p>\n
\u00a0<\/strong><\/p>\n
Question 4<\/strong><\/p>\n
Why?<\/p>\n
Correct answer:<\/em>
Show Answer<\/span><\/a><\/div>
This health claim includes scientific wording, which may cause confusion to the average consumer.<\/strong><\/div><\/p>\n
<\/p>\n
Question 5<\/strong><\/p>\n
What do you understand by \u2018characterisation\u2019 in this case? (i.e. What is it in the component of the product that has been identified as having the health effect and has this been sufficiently characterised?)<\/p>\n
Correct answer:<\/em>
Show Answer<\/span><\/a><\/div>
The food, OPC Plus, which is the subject of the health claim, is sufficiently characterised with respect to OPC extracted from grapes.<\/strong><\/div><\/p>\n
<\/p>\n
Question 6<\/strong><\/p>\n
Do you agree that the effect in question is likely to be beneficial for the general population?<\/p>\n
Correct answer:<\/em>
Show Answer<\/span><\/a><\/div>
Yes, the claim brings some confusion – alterations in the venous microcirculation (i.e., venous microangiopathy) is a consequence rather than a cause of (or a risk factor for) chronic venous insufficiency and as such, improving the \u201calterations\u201d in the venous microcirculation is not classed as a beneficial physiological effect.<\/strong><\/div><\/p>\n
<\/p>\n
Question 7<\/strong><\/p>\n
What do you think about the level of evidence provided for the scientific substantiation?<\/p>\n
You could consider:<\/p>\n
\n
Were randomized controlled trials (RCTs) in humans included<\/li>\n
Were the studies performed with the product\/compound of interest?<\/li>\n
Were the measures of the health effect valid?<\/li>\n
Was there a dose-response relationship?<\/li>\n
Was there evidence provided for a mechanism by which the product\/component has the effect?<\/li>\n<\/ol>\n
Correct answer:<\/em><\/p>\n
Show Answer<\/span><\/a><\/div>
No human intervention studies using the constituent OPC extracted from grape were provided.<\/strong><\/div>\n
<\/p>\n
Question 8<\/strong><\/p>\n
Do you think the claim was given a positive opinion?<\/p>\n
Correct answer:<\/em>
Show Answer<\/span><\/a><\/div>
No, the EFSA panel concluded that a cause and effect relationship has not been established between the consumption of OPC Plus and reducing the risk of chronic venous insufficiency by increasing microcirculation.<\/strong><\/div><\/p>\n
\u00a0<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"
OPC Plus and the risk of chronic venous insufficiency Read the following text and test your understanding on the questions below. The application Proposed wording OPC improves venous microcirculation and increases capillary resistance and therefore may reduce the risk of chronic venous insufficiency. Characterisation The product is a grape seed extract described as containing 40 […]<\/p>\n","protected":false},"author":4708,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"http:\/\/www.eurofir.org\/bacchus\/wp-json\/wp\/v2\/pages\/2201"}],"collection":[{"href":"http:\/\/www.eurofir.org\/bacchus\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/www.eurofir.org\/bacchus\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/www.eurofir.org\/bacchus\/wp-json\/wp\/v2\/users\/4708"}],"replies":[{"embeddable":true,"href":"http:\/\/www.eurofir.org\/bacchus\/wp-json\/wp\/v2\/comments?post=2201"}],"version-history":[{"count":3,"href":"http:\/\/www.eurofir.org\/bacchus\/wp-json\/wp\/v2\/pages\/2201\/revisions"}],"predecessor-version":[{"id":2222,"href":"http:\/\/www.eurofir.org\/bacchus\/wp-json\/wp\/v2\/pages\/2201\/revisions\/2222"}],"wp:attachment":[{"href":"http:\/\/www.eurofir.org\/bacchus\/wp-json\/wp\/v2\/media?parent=2201"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}